157 related articles for article (PubMed ID: 28454746)
21. Functional expression of a proton-coupled organic cation (H+/OC) antiporter in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
Shimomura K; Okura T; Kato S; Couraud PO; Schermann JM; Terasaki T; Deguchi Y
Fluids Barriers CNS; 2013 Jan; 10(1):8. PubMed ID: 23351963
[TBL] [Abstract][Full Text] [Related]
22. Diphenhydramine as a selective probe to study H
Auvity S; Chapy H; Goutal S; Caillé F; Hosten B; Smirnova M; Declèves X; Tournier N; Cisternino S
J Cereb Blood Flow Metab; 2017 Jun; 37(6):2185-2195. PubMed ID: 27488910
[TBL] [Abstract][Full Text] [Related]
23. [The blood-brain barrier transport mechanism controlling analgesic effects of opioid drugs in CNS].
Okura T; Higuchi K; Deguchi Y
Yakugaku Zasshi; 2015; 135(5):697-702. PubMed ID: 25948304
[TBL] [Abstract][Full Text] [Related]
24. A polyspecific drug/proton antiporter mediates diphenhydramine and clonidine transport at the mouse blood-retinal barrier.
Chapy H; André P; Declèves X; Scherrmann JM; Cisternino S
Br J Pharmacol; 2015 Oct; 172(19):4714-25. PubMed ID: 26177775
[TBL] [Abstract][Full Text] [Related]
25. Proton-Coupled Organic Cation Antiporter Contributes to the Hepatic Uptake of Matrine.
Wu C; Sun X; Feng C; Liu X; Wang H; Feng F; Zhang J
J Pharm Sci; 2016 Mar; 105(3):1301-6. PubMed ID: 26886331
[TBL] [Abstract][Full Text] [Related]
26. Effects of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at the blood-brain barrier and its implications to the transport of neurotoxins.
Wu KC; Lu YH; Peng YH; Hsu LC; Lin CJ
J Neurochem; 2015 Dec; 135(6):1178-88. PubMed ID: 26376205
[TBL] [Abstract][Full Text] [Related]
27. Blood-brain barrier transport of pramipexole, a dopamine D2 agonist.
Okura T; Ito R; Ishiguro N; Tamai I; Deguchi Y
Life Sci; 2007 Apr; 80(17):1564-71. PubMed ID: 17307202
[TBL] [Abstract][Full Text] [Related]
28. Carrier-Mediated Transport of Nicotine Across the Inner Blood-Retinal Barrier: Involvement of a Novel Organic Cation Transporter Driven by an Outward H(+) Gradient.
Tega Y; Kubo Y; Yuzurihara C; Akanuma S; Hosoya K
J Pharm Sci; 2015 Sep; 104(9):3069-75. PubMed ID: 25892000
[TBL] [Abstract][Full Text] [Related]
29. Possible involvement of cationic-drug sensitive transport systems in the blood-to-brain influx and brain-to-blood efflux of amantadine across the blood-brain barrier.
Suzuki T; Fukami T; Tomono K
Biopharm Drug Dispos; 2015 Mar; 36(2):126-37. PubMed ID: 25410756
[TBL] [Abstract][Full Text] [Related]
30. Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents.
Lin CJ; Tai Y; Huang MT; Tsai YF; Hsu HJ; Tzen KY; Liou HH
J Neurochem; 2010 Aug; 114(3):717-27. PubMed ID: 20477935
[TBL] [Abstract][Full Text] [Related]
31. Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier.
Ose A; Kusuhara H; Endo C; Tohyama K; Miyajima M; Kitamura S; Sugiyama Y
Drug Metab Dispos; 2010 Jan; 38(1):168-76. PubMed ID: 19833843
[TBL] [Abstract][Full Text] [Related]
32. Imperatorin is Transported through Blood-Brain Barrier by Carrier-Mediated Transporters.
Tun T; Kang YS
Biomol Ther (Seoul); 2017 Jul; 25(4):441-451. PubMed ID: 28554202
[TBL] [Abstract][Full Text] [Related]
33. Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepiandrosterone sulfate, across the blood-brain barrier in mice.
Miyajima M; Kusuhara H; Fujishima M; Adachi Y; Sugiyama Y
Drug Metab Dispos; 2011 May; 39(5):814-9. PubMed ID: 21325432
[TBL] [Abstract][Full Text] [Related]
34. Active Uptake of Oxycodone at Both the Blood-Cerebrospinal Fluid Barrier and The Blood-Brain Barrier without Sex Differences: A Rat Microdialysis Study.
Bällgren F; Hammarlund-Udenaes M; Loryan I
Pharm Res; 2023 Nov; 40(11):2715-2730. PubMed ID: 37610619
[TBL] [Abstract][Full Text] [Related]
35. Region-specific blood-brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer's disease.
Sekhar GN; Fleckney AL; Boyanova ST; Rupawala H; Lo R; Wang H; Farag DB; Rahman KM; Broadstock M; Reeves S; Thomas SA
Fluids Barriers CNS; 2019 Dec; 16(1):38. PubMed ID: 31842924
[TBL] [Abstract][Full Text] [Related]
36. Increased penetration of diphenhydramine in brain via proton-coupled organic cation antiporter in rats with lipopolysaccharide-induced inflammation.
Kawase A; Chuma T; Irie K; Kazaoka A; Kakuno A; Matsuda N; Shimada H; Iwaki M
Brain Behav Immun Health; 2021 Jan; 10():100188. PubMed ID: 34589723
[TBL] [Abstract][Full Text] [Related]
37. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.
Mihalak KB; Carroll FI; Luetje CW
Mol Pharmacol; 2006 Sep; 70(3):801-5. PubMed ID: 16766716
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning, functional characterization and tissue distribution of rat H+/organic cation antiporter MATE1.
Terada T; Masuda S; Asaka J; Tsuda M; Katsura T; Inui K
Pharm Res; 2006 Aug; 23(8):1696-701. PubMed ID: 16850272
[TBL] [Abstract][Full Text] [Related]
39. Functional expression of choline transporter like-protein 1 (CTL1) and CTL2 in human brain microvascular endothelial cells.
Iwao B; Yara M; Hara N; Kawai Y; Yamanaka T; Nishihara H; Inoue T; Inazu M
Neurochem Int; 2016 Feb; 93():40-50. PubMed ID: 26746385
[TBL] [Abstract][Full Text] [Related]
40. Involvement of the H+/organic cation antiporter in nicotine transport in rat liver.
Tega Y; Akanuma S; Kubo Y; Hosoya K
Drug Metab Dispos; 2015 Jan; 43(1):89-92. PubMed ID: 25352656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
